Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis

Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis

Ning Zhang,1 Changqing Zhang,2 Zhihong Zeng,1 Jiyong Zhang,1 Shengnan Du,1 Chunde Bao,3 Zhe Wang1 1Longwood Biopharmaceuticals, Shanghai, People’s Republic of China; 2Department of Orthopaedics, Shanghai Sixth People’s Hospital, Shanghai, People’s Republic of China; 3De...

Full description

Bibliographic Details
Main Authors: Zhang N, Zhang C, Zeng Z, Zhang J, Du S, Bao C, Wang Z
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Journal of Inflammation Research
Subjects:
rheumatoid arthritis
jak1 inhibitor
rat aia model
mouse cia
Online Access:https://www.dovepress.com/preclinical-characterization-of-the-selective-jak1-inhibitor-lw402-for-peer-reviewed-fulltext-article-JIR

Internet

https://www.dovepress.com/preclinical-characterization-of-the-selective-jak1-inhibitor-lw402-for-peer-reviewed-fulltext-article-JIR

Similar Items